Safety and Efficacy of GMP Clinical Grade Manufacturing of Virus Specific Cytotoxic T Lymphocytes (vCTLS) Against Cytomegalovirus (CMV), Epstein Barr Virus ( EBV), Adenovirus (ADV) and BKV to Treat Medically Refractory Viral Infections Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) in Children, Adolescents and Young Adults (CAYA) (IND# 17449)

Autor: Bernadette Fallon, Rosemarie Shaw, Nancy Bunin, Yongping Wang, Robert Kuhns, Lynn O'Donnell, Lauren Harrison, Isabel D Gonzalez, Janet Ayello, Erin Morris, Olivia Rigot, Dean Anthony Lee, Allyson Flower, Julie-An Talano, Meghan Sturhahn, Mitchell S. Cairo, Lin Marie Colon, Bryon D. Johnson
Rok vydání: 2021
Předmět:
Zdroj: Transplantation and Cellular Therapy. 27:S338-S339
ISSN: 2666-6367
DOI: 10.1016/s2666-6367(21)00435-8
Databáze: OpenAIRE